Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer (Q84529291)
Jump to navigation
Jump to search
scientific article published on 07 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer |
scientific article published on 07 July 2011 |
Statements
Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer (English)
Kathrin Schwedler
Marcus Schmidt
Jana Barinoff
Christoph Mundhenke
Tanja Cufer
Eduard Maartense
Felix E de Jongh
Klaus H Baumann
Joachim Bischoff
Nadia Harbeck
Hans-Joachim Lück
Nicolai Maass
Christoph Zielinski
Michael Andersson
Valentina Nekljudova
Sibylle Loibl
GBG 26/BIG 03-05 study group and participating investigators